Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study

Clinical trial NCT01543178 · COMPLETED

Trial details

NCT number: NCT01543178
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea

Start date: 2012-02-01
Primary completion: 2014-06-01
Enrollment: 2583

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.